Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.
Ultragenyx Pharmaceutical Inc. RARE shares are down on Thursday as the company reported data from its Phase 3 study of DTX301, a gene therapy for ornithine transcarbamylase (OTC) deficiency. • ...
Detecting high ammonia levels in your blood can help doctors diagnose and treat liver disease before it progresses and becomes life threatening. Ammonia is a substance made of hydrogen and nitrogen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results